<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="36707">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01761721</url>
  </required_header>
  <id_info>
    <org_study_id>H-2-2012-FSP26</org_study_id>
    <nct_id>NCT01761721</nct_id>
  </id_info>
  <brief_title>Robot-assisted Laparoscopic Hysterectomy-RALH- Postoperative Complications, Quality of Life and Health Economics</brief_title>
  <acronym>RALH</acronym>
  <official_title>Robot-assisted Laparoscopic Hysterectomy-RALH- Postoperative Complications, Quality of Life and Health Economics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Copenhagen University Hospital at Herlev</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Copenhagen University Hospital at Herlev</source>
  <oversight_info>
    <authority>Denmark: Danish Dataprotection Agency</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The propose of this study is to describe recovery and experience of pain and health related
      quality of life after robot-assisted laparoscopic hysterectomy for women with Endometrial
      Cancer or Atypical Complex Hyperplasia.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>4 Months</target_duration>
  <primary_outcome>
    <measure>Postoperative complications   Postoperative complications   Postoperative complications   Postoperative complications</measure>
    <time_frame>0-4 months follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>Postoperative complications demanding treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>0-4 months follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>Postoperative pain measured by Brief Pain Inventory, baseline, 1 and 5 weeks and 4 months postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Related Quality of Life</measure>
    <time_frame>0-4 months follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>Health Related Quality of Life measured by QlQ-C30 and EN 24 (EORTC), EQ -5D, baseline, 1 and 5 weeks and 4 months postoperatively.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Endometrial Cancer</condition>
  <condition>Treatment by Robotic Assisted Laparoscopy Hysterectomy</condition>
  <arm_group>
    <arm_group_label>RAHL</arm_group_label>
    <description>Women suspected of endometrial cancer planned to be treated by robotic assisted laparoscopy hysterectomy</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Women suspected of endometrial cancer and treated with robot-assisted laparoscopic
        hysterectomy at Copenhagen University Hospital, Herlev.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Women suspected of having Endometrial Cancer or having Atypical Complex hyperplasia

          -  Ability to understand and speak Danish

          -  Ability to cooperate

          -  Provision of written informed consent

        Exclusion Criteria:

          -  Having a benign condition after histopathology postoperatively

          -  Bing assigned to radiation or chemotherapy postoperatively
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Suzanne F Herling, RN; MHSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anaesthesiology, Copenhagen University Hospital, Herlev</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Suzanne F Herling, RN; MHSc</last_name>
    <phone>+45 38683595</phone>
    <email>Suzanne.forsyth.herling@regionh.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ann M Moeller, DMSc</last_name>
    <phone>+45 38682879</phone>
    <email>annmoeller@regionh.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Anaesthesiology, Copenhagen University Hospital, Herlev</name>
      <address>
        <city>Herlev</city>
        <zip>2730</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzanne F Herling, RN; MHSc</last_name>
      <phone>+45 38683595</phone>
      <email>Suzanne.forsyth.herling@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Ann M Moeller, DMSc</last_name>
      <phone>+45 38682879</phone>
      <email>annmoeller@regionh.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Suzanne F Herling, RN; MHSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 3, 2013</lastchanged_date>
  <firstreceived_date>January 3, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Endometrial cancer (MeSH)</keyword>
  <keyword>Robotics (MeSH)</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Endometrial Neoplasms</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
